• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声造影与 MRI 门静脉期成像的独特不匹配:肝内胆管细胞癌的有价值预测指标?

Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma?

机构信息

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Division of Gastroenterology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.

出版信息

Abdom Radiol (NY). 2024 Jan;49(1):11-20. doi: 10.1007/s00261-023-04031-8. Epub 2023 Oct 7.

DOI:10.1007/s00261-023-04031-8
PMID:37804423
Abstract

PURPOSE

We have long noted unique portal venous phase (PVP) imaging discordance of focal liver masses between CEUS, showing rapid marked washout, and MRI, showing progressive or sustained enhancement. We postulate association of this unique discordance with intrahepatic cholangiocarcinoma (ICC) and causal relationship to different contrast agent behavior. We investigate this unique discordance, propose its clinical significance for ICC diagnosis, and confirm further histologic associations.

METHODS

Cases were collected within our CEUS department and from pathology records over a ten-year interval. This retrospective review includes 99 patients, 73 with confirmed ICC and 26 other diagnoses, showing unique PVP discordance. The CEUS and MRI enhancement characteristics were compared for all patients.

RESULTS

Unique discordance is identified in 67/73 (92%) ICC and difference between the PVP appearance on MRI and CEUS is statistically significant (p <  0.0001). Arterial phase enhancement did not show statistically significant difference between CEUS and MRI, p >  0.05. Other diagnoses showing unique discordance include especially lymphoma (n = 7), sclerosed hemangioma (n = 6), HCC (n = 4), metastases (n = 2), and other rare entities.

CONCLUSION

ICC shows this discrepant intermodality enhancement pattern in a statistically significant number of cases and should be considered along with other LR-M features in at-risk patients. Discordance is also rarely seen in a number of other liver lesions.

摘要

目的

我们长期以来注意到,CEUS 显示快速显著廓清,而 MRI 显示渐进性或持续性增强,两者之间局灶性肝脏肿块的门静脉期(PVP)成像存在独特的不匹配,我们推测这种独特的不匹配与肝内胆管细胞癌(ICC)有关,并与不同的对比剂行为存在因果关系。我们调查了这种独特的不匹配现象,提出了其对 ICC 诊断的临床意义,并进一步证实了组织学相关性。

方法

本研究为回顾性研究,在十年的时间间隔内,我们在超声造影部门收集病例,并从病理记录中获取病例。本研究纳入了 99 例患者,其中 73 例经病理证实为 ICC,26 例为其他诊断,均表现出独特的 PVP 不匹配。比较了所有患者的 CEUS 和 MRI 增强特征。

结果

在 73 例 ICC 中,有 67 例(92%)存在独特的不匹配,MRI 和 CEUS 上 PVP 表现之间存在统计学显著差异(p < 0.0001)。CEUS 和 MRI 的动脉期增强无统计学显著差异,p > 0.05。其他表现出独特不匹配的诊断包括淋巴瘤(n = 7)、硬化性血管瘤(n = 6)、HCC(n = 4)、转移瘤(n = 2)和其他罕见实体。

结论

ICC 在具有统计学意义数量的病例中表现出这种不一致的模态增强模式,应结合其他 LR-M 特征在高危患者中进行考虑。这种不匹配在一些其他肝脏病变中也很少见。

相似文献

1
Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma?超声造影与 MRI 门静脉期成像的独特不匹配:肝内胆管细胞癌的有价值预测指标?
Abdom Radiol (NY). 2024 Jan;49(1):11-20. doi: 10.1007/s00261-023-04031-8. Epub 2023 Oct 7.
2
Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.动态对比增强超声在非肝硬化肝脏肝细胞癌和肝内胆管细胞癌鉴别诊断中的应用。
Ultrasound Med Biol. 2023 Aug;49(8):1780-1788. doi: 10.1016/j.ultrasmedbio.2023.03.026. Epub 2023 May 6.
3
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
4
Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.高危患者肝内胆管细胞癌与肝细胞癌的鉴别诊断:应用超声造影的预测模型。
World J Gastroenterol. 2018 Sep 7;24(33):3786-3798. doi: 10.3748/wjg.v24.i33.3786.
5
Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.超声造影在鉴别肝细胞癌和胆管细胞癌中的应用。
Ultraschall Med. 2012 Dec;33(7):E191-E195. doi: 10.1055/s-0031-1282029. Epub 2011 Dec 22.
6
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.超声造影肝脏影像报告与数据系统:在肝细胞癌和胆管细胞癌诊断中的优缺点。
World J Gastroenterol. 2022 Jul 21;28(27):3488-3502. doi: 10.3748/wjg.v28.i27.3488.
7
Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.对比增强超声对时间特征的详细分析可能有助于鉴别肝硬化患者肝内胆管癌与肝细胞癌。
PLoS One. 2014 May 29;9(5):e98612. doi: 10.1371/journal.pone.0098612. eCollection 2014.
8
Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.磁共振成像和超声造影对鉴别肝内胆管细胞癌与肝细胞癌的诊断性能:荟萃分析。
Abdom Radiol (NY). 2024 Jan;49(1):34-48. doi: 10.1007/s00261-023-04064-z. Epub 2023 Oct 12.
9
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?增强超声能区分肝内胆管细胞癌和肝细胞癌吗?
World J Gastroenterol. 2020 Jul 21;26(27):3938-3951. doi: 10.3748/wjg.v26.i27.3938.
10
Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.超声造影在鉴别小(≤3厘米)肝细胞癌与肝内胆管癌中的特征
Medicine (Baltimore). 2018 Oct;97(41):e12781. doi: 10.1097/MD.0000000000012781.

引用本文的文献

1
The impact of ultrasound contrast-enhanced fusion virtual navigation technology-guided microwave ablation (MWA) and standard MWA on the local tumor progression of hepatocellular carcinoma with unclear ultrasound images.超声造影增强融合虚拟导航技术引导下的微波消融(MWA)与标准MWA对超声图像不清晰的肝细胞癌局部肿瘤进展的影响
Eur J Med Res. 2025 Jun 4;30(1):451. doi: 10.1186/s40001-025-02608-1.
2
The post-surgical liver: is application of treatment response assessment within the CEUS LI-RADS framework possible?术后肝脏:在CEUS LI-RADS框架内应用治疗反应评估是否可行?
Abdom Radiol (NY). 2025 Jun 4. doi: 10.1007/s00261-025-05046-z.
3

本文引用的文献

1
Use of CEUS LI-RADS for the Accurate Diagnosis of Nodules in Patients at Risk for Hepatocellular Carcinoma: A Validation Study.使用CEUS LI-RADS对肝细胞癌高危患者的结节进行准确诊断:一项验证研究。
Radiol Imaging Cancer. 2020 Mar 27;2(2):e190014. doi: 10.1148/rycan.2020190014. eCollection 2020 Mar.
2
Characterization of Focal Liver Masses: A Multicenter Comparison of Contrast-Enhanced Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.肝脏局灶性病变的特征分析:超声造影、计算机断层扫描和磁共振成像的多中心比较。
J Ultrasound Med. 2021 Dec;40(12):2581-2593. doi: 10.1002/jum.15644. Epub 2021 Feb 12.
3
Ultrasound innovations in abdominal radiology: evaluation of focal liver lesions.
腹部放射学中的超声创新:肝脏局灶性病变的评估
Abdom Radiol (NY). 2025 May 10. doi: 10.1007/s00261-025-04970-4.
4
Occult liver nodules: their detection and characterization with CEUS.隐匿性肝结节:对比增强超声对其的检测与特征分析
Abdom Radiol (NY). 2025 Jan 18. doi: 10.1007/s00261-024-04651-8.
5
Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound.肝细胞-胆管细胞癌的临床病理及超声特征及其与微血管侵犯的相关性:超声造影的预测作用
Front Oncol. 2024 Dec 20;14:1474675. doi: 10.3389/fonc.2024.1474675. eCollection 2024.
6
I thought it was a hemangioma! A pictorial essay about common and uncommon liver hemangiomas' mimickers.我原以为那是个血管瘤!一篇关于常见及罕见的肝脏血管瘤模仿者的图文并茂的文章。
Insights Imaging. 2024 Sep 19;15(1):228. doi: 10.1186/s13244-024-01745-1.
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
4
Contrast-enhanced US Approach to the Diagnosis of Focal Liver Masses.超声造影在肝脏局灶性肿块诊断中的应用
Radiographics. 2017 Sep-Oct;37(5):1388-1400. doi: 10.1148/rg.2017170034.
5
Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.对比增强超声用于肝细胞癌和肝内胆管癌的特征性诊断
Liver Cancer. 2015 Dec;4(4):241-52. doi: 10.1159/000367738. Epub 2015 Oct 21.
6
The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.超声造影中对比剂廓清程度在鉴别肝内胆管癌与肝细胞癌中的应用
Ultrasound Med Biol. 2015 Dec;41(12):3088-95. doi: 10.1016/j.ultrasmedbio.2015.08.001. Epub 2015 Sep 19.
7
Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.肝内胆管癌在超声造影上的动态增强模式:与肝硬化及肿瘤大小的相关性
Abdom Imaging. 2015 Aug;40(6):1558-66. doi: 10.1007/s00261-015-0379-y.
8
Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.对比增强超声对时间特征的详细分析可能有助于鉴别肝硬化患者肝内胆管癌与肝细胞癌。
PLoS One. 2014 May 29;9(5):e98612. doi: 10.1371/journal.pone.0098612. eCollection 2014.
9
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.肝硬化患者在超声造影下肝内胆管细胞癌的表现模式及误诊风险。
Liver Int. 2013 May;33(5):771-9. doi: 10.1111/liv.12124. Epub 2013 Feb 27.
10
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.